Share on :

Asset Summary

Weekly Performance Report for VTRS ETF: Week 50, 2024

Summary: The Weekly started with VTRS ETF opening at $12.64 and closing at $12.82. The ETF showed resilience throughout the Weekly, with the highest price observed at $13.13 and the lowest at $12.37. The underlying asset had a trading range of $0.76 Overall, it was a positive trading Weekly for VTRS ETF, reflecting investor optimism and market activity.

Change in Closing Price: There was a net increase of $0.18 or 1.42% in the closing price from the opening to the closing price over the Weekly.

Volume Analysis: Trading volume for VTRS ETF was 34,811,333 units during Week 50, indicating active market participation and investor interest.

Opening Price: The Weekly started at $12.64.

Highest Price: The highest price observed during the Weekly was $13.13.

Lowest Price: The lowest price observed during the Weekly was $12.37.

Closing Price: The Weekly ended at $12.82.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Advance Your VTRS Trading Now

Transform your approach to trading with RankMyTrade.com. Our automated system offers detailed metrics and technical analysis for VTRS, tailored to enhance your trading performance. Start optimizing your trades today and elevate your strategy today!

Boost Performance Now

Frequently Asked Questions

Viatris operates in several key business segments, including generic pharmaceuticals, brand-name products, and over-the-counter medications.

Yes, Viatris Inc. is publicly traded on the Nasdaq under the ticker symbol VTRS.

Investors can stay informed about Viatris through its investor relations website, which provides financial reports, press releases, and updates.

Viatris participates in global health initiatives through donations, partnerships, and programs aimed at improving health outcomes in underserved communities.

Viatris focuses on a variety of therapeutic areas, including infectious diseases, oncology, and cardiovascular health.

Viatris faces challenges such as pricing pressures, competition in the pharmaceutical market, and regulatory hurdles.

Viatris is dedicated to sustainability, focusing on reducing its environmental impact and promoting responsible manufacturing practices.

Viatris engages with healthcare professionals through educational initiatives, research collaborations, and product support programs.

Viatris emphasizes strong corporate governance practices to ensure accountability and transparency in its operations.

Viatris was formed in 2020 through the merger of Mylan N.V. and Upjohn, a division of Pfizer.

Enhance Your VTRS Trading Now

Revolutionize your investment in VTRS with Rank My Trade’s innovative trading solutions. Benefit from our comprehensive risk management features and sophisticated price analysis tools. Elevate your trading approach instantly with Rank My Trade now and achieve better trading outcomes!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs